General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novo Nordisk Inc.(SIGNIFICANT), Merck & Co., Inc.(MODEST), GlaxoSmithKline(MODEST), AstraZeneca Pharmaceuticals(MODEST), Amgen Inc.(MODEST), Sanofi-Pasteur(SIGNIFICANT)

View Full Disclosure